Benjamin RS - Search Results

1

Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications.

Jiang Y, Janku F, Subbiah V, Angelo LS, Naing A, Anderson PM, Herzog CE, Fu S, Benjamin RS, Kurzrock R. Jiang Y, et al. Among authors: benjamin rs. Oncotarget. 2013 Jun;4(6):884-9. doi: 10.18632/oncotarget.1021. Oncotarget. 2013. PMID: 23800680 Free PMC article.

2

Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma.

Cormier JN, Patel SR, Herzog CE, Ballo MT, Burgess MA, Feig BW, Hunt KK, Raney RB, Zagars GK, Benjamin RS, Pisters PW. Cormier JN, et al. Among authors: benjamin rs. Cancer. 2001 Sep 15;92(6):1550-5. doi: 10.1002/1097-0142(20010915)92:6<1550::aid-cncr1481>3.0.co;2-c. Cancer. 2001. PMID: 11745234 Review.

3

Risks and benefits of phase 1 oncology trials, revisited.

Kurzrock R, Benjamin RS. Kurzrock R, et al. Among authors: benjamin rs. N Engl J Med. 2005 Mar 3;352(9):930-2. doi: 10.1056/NEJMe058007. N Engl J Med. 2005. PMID: 15745986 No abstract available.

4

Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma.

Lin PP, Jaffe N, Herzog CE, Costelloe CM, Deavers MT, Kelly JS, Patel SR, Madewell JE, Lewis VO, Cannon CP, Benjamin RS, Yasko AW. Lin PP, et al. Among authors: benjamin rs. Cancer. 2007 Feb 1;109(3):603-11. doi: 10.1002/cncr.22412. Cancer. 2007. PMID: 17177205 Free article.

5

Of mice and men: divergent risks of teriparatide-induced osteosarcoma.

Subbiah V, Madsen VS, Raymond AK, Benjamin RS, Ludwig JA. Subbiah V, et al. Among authors: benjamin rs. Osteoporos Int. 2010 Jun;21(6):1041-5. doi: 10.1007/s00198-009-1004-0. Epub 2009 Jul 14. Osteoporos Int. 2010. PMID: 19597911

6

Neoadjuvant treatment of soft-tissue sarcoma: a multimodality approach.

Reynoso D, Subbiah V, Trent JC, Guadagnolo BA, Lazar AJ, Benjamin R, Pollock RE, Ludwig JA. Reynoso D, et al. J Surg Oncol. 2010 Mar 15;101(4):327-33. doi: 10.1002/jso.21481. J Surg Oncol. 2010. PMID: 20187067 Review.

7

A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors.

Kurzrock R, Patnaik A, Aisner J, Warren T, Leong S, Benjamin R, Eckhardt SG, Eid JE, Greig G, Habben K, McCarthy CD, Gore L. Kurzrock R, et al. Clin Cancer Res. 2010 Apr 15;16(8):2458-65. doi: 10.1158/1078-0432.CCR-09-3220. Epub 2010 Apr 6. Clin Cancer Res. 2010. PMID: 20371689 Clinical Trial.

8

Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.

Subbiah V, Naing A, Brown RE, Chen H, Doyle L, LoRusso P, Benjamin R, Anderson P, Kurzrock R. Subbiah V, et al. PLoS One. 2011 Apr 6;6(4):e18424. doi: 10.1371/journal.pone.0018424. PLoS One. 2011. PMID: 21494688 Free PMC article.

9

Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors.

Naing A, LoRusso P, Fu S, Hong DS, Anderson P, Benjamin RS, Ludwig J, Chen HX, Doyle LA, Kurzrock R. Naing A, et al. Among authors: benjamin rs. Clin Cancer Res. 2012 May 1;18(9):2625-31. doi: 10.1158/1078-0432.CCR-12-0061. Epub 2012 Mar 31. Clin Cancer Res. 2012. PMID: 22465830 Free PMC article. Clinical Trial.

10

Dual targeting of the insulin-like growth factor and collateral pathways in cancer: combating drug resistance.

Ludwig JA, Lamhamedi-Cherradi SE, Lee HY, Naing A, Benjamin R. Ludwig JA, et al. Cancers (Basel). 2011 Jul 26;3(3):3029-54. doi: 10.3390/cancers3033029. Cancers (Basel). 2011. PMID: 24212944 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page